RELENZA (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the RELENZA drug offered from GlaxoSmithKline LLC. This Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | zanamivir |
| SUBSTANCE NAME: | ZANAMIVIR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | POWDER |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-09-22 |
| END MARKETING DATE: | 0000-00-00 |
RELENZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | RELENZA from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 1999-09-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0173-0681_0f2e4250-582a-49f6-9615-e4bb5f566271 |
| PRODUCT NDC: | 0173-0681 |
| APPLICATION NUMBER: | NDA021036 |
Other ZANAMIVIR Pharmaceutical Manufacturers / Labelers:
